The present study demonstrated that the local administration of rolipram in the L5 DRG ameliorated marked mechanical hyperalgesia induced by paclitaxel in a rat model of chemotherapy-induced neuropathic pain via inhibition of inflammatory cytokines and PDE4. This evidence concerns the gene PDE4A and Pain.